活动悬崖意识强化学习用于新的药物设计
Xiuyuan Hu1, Guoqing Liu2, Yang Zhao1
1Department of Electronic Engineering, Tsinghua University, Beijing, China.
Journal of cheminformatics
|April 21, 2025
概括
我们推出了活动悬崖意识强化学习 (ACARL) 框架,以改善药物发现中的人工智能 (AI). ACARL通过专注于关键结构-活性关系 (SAR) 变化来增强分子设计,从而产生更好的候选药物.
科学领域:
- 计算化学是一种计算化学.
- 药品化学 药品化学 是一个
- 人工智能在药物发现中的作用
背景情况:
- 传统的药物发现在模拟复杂的结构-活性关系 (SAR),特别是活性悬崖方面面临挑战.
- 现有的人工智能 (AI) 模型难以捕捉分子设计中的这些关键不连续性.
研究的目的:
- 开发一种新的AI框架,活动悬崖意识强化学习 (ACARL),用于新的分子设计.
- 改进SAR的建模,特别是活动悬崖,在AI驱动的药物发现管道中.
主要方法:
- 提出了活动悬崖意识强化学习 (ACARL) 框架.
- 开发了一种新的活动悬崖指数,以识别和放大表现出活动悬崖的化合物.
- 将活动悬崖化合物纳入强化学习 (RL) 过程中,使用定制的对比损失函数.
主要成果:
- 与最先进的算法相比,ACARL在生成跨多个蛋白质点的高亲和度分子方面表现出卓越的表现.
- 该框架有效地将SAR原则集成到基于RL的药物设计管道中.
- ACARL成功地将模型优化重点放在高影响SAR地区,改进了目标物业生成.
结论:
- ACARL通过明确建模活动悬崖,为de novo分子设计提供了一个强大的方法.
- 该框架代表了人工智能驱动的药物发现的重大进步,提高了机器学习应用程序的可靠性和范围.
- 这项工作强调了将域名知识与机器学习结合起来,以应对复杂的SAR挑战的有效性.
相关概念视频
01:26Drug Discovery: Overview
7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K
01:28Structure-Activity Relationships and Drug Design
437
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
437
01:28Preclinical Development: Overview
4.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.0K
01:26Targets for Drug Action: Overview
5.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
5.9K
01:20Desensitization and Tachyphylaxis
1.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.4K
01:30Quantitative Aspects of Drug-Receptor Interaction
889
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
889